Patient Care

COVID-19 Treatment Guidelines 

• MHC COVID-19 Treatment Guidelines - 5.14.24
• MDHHS COVID-19 Outpatient Therapeutics Toolkit - July 2022

COVID-19 Infection in Children and MIS-C

• Caring for Children With Acute Illness in the Ambulatory Care Setting During the Public Health Emergency 

COVID-19 Oral Antivirals 

• Oral Antivirals Prescribing Information and Script Template
• Oral Antiviral Eligibility and Prioritization Criteria
• COVID-19 Therapeutics Locator
• Meijer COVID-19 Oral Therapeutic Program
• CDC Health Advisory for Use of Oral Antivirals 

Paxlovid

• COVID-19 Treatment: Safe Paxlovid Prescribing Quick Guide
• CDC Health Advisory: COVID-19 Rebound After Paxlovid Treatment
• Paxlovid FDA Patient Eligibility Screening Checklist Tool for Prescribers
• Paxlovid FDA Fact Sheet for Patients & Caregivers
• Paxlovid FDA Fact Sheet for Healthcare providers
• U of M Paxlovid Drug Interaction Guidance 
• Liverpool COVID-19 Drug Interaction Checker

Molnupiravir

• Molnupiravir FDA Fact Sheet for Patients & Caregivers
• Molnupiravir FDA Fact Sheet for Healthcare providers

Post-Acute Care COVID-19 Patients 

• Mary Free Bed: Recovery Program Post COVID-19 Outpatient Rehabilitation 
• CDC Guidelines for the treatment of COVID long-haulers

Long COVID Support Group

• MDHHS Long COVID support group 

Information for Your Patients and Their Families

• Stay Well - Mental Health Resources and Support Groups
• COVID-19: How to Build Community Immunity 
• MHC Current Visitor Restrictions

Ask-A-Nurse-Line

Clinical questions and support: Ask-a-Nurse Line 231-935-0951 - press 5 (available 24 hours a day)